http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014183665-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_078cb8366425c7f7bb46338421d23406
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4439
filingDate 2014-05-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e9af814d88815607f10b35185514efeb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a22828c9984ff97f0ddbeb24b656135f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e91259b8a90e5666bfad7400c3316c00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c6a9b539d62d9e6aa535fd6949c438bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8a80f4c70f374c6707fe3b2bd31bd63
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5117e14f03070dc1de424f60c58e1bfb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28dc7846d78a66f4fbb44530523c4244
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c36aab213897693f3931f7d4320e5c4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_28b3f92b5a1ad2eef799c8bdbf54abc9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_913a23bb6f6f114a665cfa483acd4118
publicationDate 2014-11-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2014183665-A1
titleOfInvention Oxazolidinone derivative crystal form i and preparation method and use thereof
abstract Provided is the crystal form I of (S)-5-chloro-N-((2-oxo-3-(4-(2-oxo-2H-pyridine-1-yl)phenyl)-1,3-oxazolidine-5-yl)methyl)thiophene-2-formamide, and preparation method and use thereof. The prepared crystal form I of (S)-5-chloro-N-((2-oxo-3-(4-(2-oxo-2H-pyridine-1-yl)phenyl)-1,3-oxazolidine-5-yl)methyl)thiophene-2-formamide is characterised by an X-ray powder diffractogram.
priorityDate 2013-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2008155069-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-102464658-A
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127788191
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127537457
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID247062025
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73949
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127392859
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID249287714
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129205934
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11535695
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID327987029
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID311049865
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID60172452
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID322968437
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21601
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID324661127
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID322541768
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128244517
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID323059954
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID58618158
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123523139
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID123267262
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129345209
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID58618155
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID427709235
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8871
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID246968542
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7813
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID589223

Total number of triples: 54.